Emerald Advisers’s Exelixis EXEL Stock Holding History

Emerald Advisers’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-710,248	Closed	-$15.4M	–	237
2017 Q1	$15.4M	Sell	710,248 -596,421	-46%	-$12.1M	0.63%	63
2016 Q4	$19.5M	Buy	+1,306,669	New	+$18.9M	0.83%	47

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

Emerald Advisers's EXEL Position: Q2 2017 in Review

Emerald Advisers sold out of Exelixis (EXEL) in Q2 2017, closing a stake of 710,248 shares — an estimated $15.4M sold.

Emerald Advisers first reported a position in EXEL in Q4 2016 and held it in 2 quarters. The position peaked at $19.5M in Q4 2016. 249 funds tracked by Wall St. Rank hold EXEL as of Q2 2017.

Emerald Advisers reported no remaining Exelixis position as of Q2 2017 after selling out during the quarter.
Emerald Advisers sold 710,248 Exelixis shares in Q2 2017, an estimated $15.4M.
Emerald Advisers first reported a position in Exelixis in Q4 2016 and held it in 2 quarters.
Emerald Advisers's Exelixis position peaked at $19.5M in Q4 2016.
249 funds tracked by Wall St. Rank held Exelixis as of Q2 2017.

Based on Emerald Advisers's 13F filing for Q2 2017, filed 28 Jul 2017.